{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:07:31Z","timestamp":1777468051753,"version":"3.51.4"},"reference-count":15,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2024,3,14]]},"abstract":"<jats:p>INTRODUCTION: Chemotherapy is conventionally offered to non-stage IV breast cancer patients with metastatic nodes. However, the RxPONDER trial showed that chemotherapy can be omitted in selected patients with 1\u20133 metastatic nodes if the 21-gene assay recurrence score is \u226425. We aimed to investigate if axillary ultrasound can identify this group of patients with limited nodal burden so that they can undergo upfront surgery followed by gene assay testing, to potentially avoid chemotherapy. METHODS: T1-3, node positive, hormone receptor-positive and HER2-negative breast cancer patients \u226550 years old with axillary lymph node dissection (ALND) were reviewed from 2 centres. Patients with neoadjuvant chemotherapy and bilateral cancers were excluded. Number of ultrasound-detected abnormal axillary nodes, demographic and histological parameters were correlated with the number of metastatic nodes found on ALND. RESULTS: 138 patients were included, 59 (42.8%) and 79 (57.2%) patients had 1\u20133 and &gt;3 metastatic nodes on ALND respectively. On logistic regression and ROC analysis, the number of ultrasound-detected abnormal nodes was significant (p &lt;\u00a00.001) for predicting limited nodal burden (ROC AUC = 0.7135). Probabilities of &lt;4 metastatic nodes with ultrasound cut-offs of 5, 6 and 8 abnormal nodes were 0.057, 0.026 and 0.005 respectively, with 100% specificity. CONCLUSION: A cut-off of \u22645 ultrasound-detected abnormal nodes can distinguish between patients with limited versus high nodal burden, with high specificity. Hence, incorporating the number of abnormal ultrasound-detected nodes into clinical practice may prove useful in guiding between upfront surgery and gene assay testing or neoadjuvant chemotherapy in this group of patients.<\/jats:p>","DOI":"10.3233\/bd-230032","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T11:59:08Z","timestamp":1710503948000},"page":"19-23","source":"Crossref","is-referenced-by-count":1,"title":["Use of axillary ultrasound to guide breast cancer management in the genomic assay era"],"prefix":"10.1177","volume":"43","author":[{"given":"Geok Hoon","family":"Lim","sequence":"first","affiliation":[{"name":", , Singapore"},{"name":", Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Carson","family":"Allen","sequence":"additional","affiliation":[{"name":", Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yien Sien","family":"Lee","sequence":"additional","affiliation":[{"name":", KK Women\u2019s and Children\u2019s Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sze Yiun","family":"Teo","sequence":"additional","affiliation":[{"name":", KK Women\u2019s and Children\u2019s Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Ching","family":"Lau","sequence":"additional","affiliation":[{"name":", KK Women\u2019s and Children\u2019s Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thida","family":"Win","sequence":"additional","affiliation":[{"name":", KK Women\u2019s and Children\u2019s Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lester Chee Hao","family":"Leong","sequence":"additional","affiliation":[{"name":", Singapore General Hospital, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/BD-230032_ref1","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3233\/BD-230032_ref2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/cam4.2848","article-title":"Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial)","volume":"9","author":"Lim","year":"2020","journal-title":"Cancer Med"},{"key":"10.3233\/BD-230032_ref3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ans.12975","article-title":"Utility of neoadjuvant chemotherapy in the treatment of operable breast cancer","volume":"85","author":"Read","year":"2015","journal-title":"ANZ J Surg"},{"key":"10.3233\/BD-230032_ref4","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1245\/s10434-017-5898-z","article-title":"Standard pathologic features can be used to identify a subset of estrogen receptor-positive, Her2 negative patients likely to benefit from neoadjuvant chemotherapy","volume":"24","author":"Petruolo","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4S Suppl 3","key":"10.3233\/BD-230032_ref5","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1097\/SAP.0000000000001864","article-title":"Lymphedema incidence after axillary lymph node dissection: Quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach","volume":"82","author":"Johnson","year":"2019","journal-title":"Ann Plast Surg"},{"key":"10.3233\/BD-230032_ref6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jss.2020.12.007","article-title":"Impact of breast cancer pretreatment nodal burden and disease subtype on axillary surgical management","volume":"261","author":"Ng","year":"2021","journal-title":"J Surg Res"},{"key":"10.3233\/BD-230032_ref7","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1245\/s10434-017-6085-y","article-title":"Tumor biology predicts pathologic complete response to neoadjuvant chemotherapy in patients presenting with locally advanced breast cancer","volume":"24","author":"Gentile","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.3233\/BD-230032_ref8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinimag.2021.03.002","article-title":"Association of the initial number of sonographically abnormal nodes with nodal pathological response and its implication","volume":"78","author":"Yan","year":"2021","journal-title":"Clin Imaging"},{"key":"10.3233\/BD-230032_ref9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1186\/s12885-020-07505-w","article-title":"Utility of 18F-FDG PET\/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Cancer"},{"key":"10.3233\/BD-230032_ref10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/radiol.2020192534","article-title":"Axillary nodal evaluation in breast cancer: State of the art","volume":"295","author":"Chang","year":"2020","journal-title":"Radiology"},{"key":"10.3233\/BD-230032_ref11","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1634\/theoncologist.2019-0427","article-title":"Lymph node imaging in patients with primary breast cancer: Concurrent diagnostic tools","volume":"25","author":"Marino","year":"2020","journal-title":"Oncologist"},{"key":"10.3233\/BD-230032_ref12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/tbj.13635","article-title":"Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging","volume":"26","author":"Upadhyaya","year":"2020","journal-title":"Breast\u00a0J"},{"key":"10.3233\/BD-230032_ref13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4048\/jbc.2019.22.e8","article-title":"Determining whether high nodal burden in early breast cancer patients can be predicted preoperatively to avoid sentinel lymph node biopsy","volume":"22","author":"Lim","year":"2019","journal-title":"J Breast Cancer"},{"key":"10.3233\/BD-230032_ref14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ejso.2018.04.003","article-title":"Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result","volume":"44","author":"Lim","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.3233\/BD-230032_ref15","doi-asserted-by":"crossref","first-page":"e1621","DOI":"10.1634\/theoncologist.2020-0494","article-title":"Would removal of all ultrasound abnormal metastatic lymph nodes without sentinel lymph node biopsy be accurate in patients with breast cancer with neoadjuvant chemotherapy?","volume":"25","author":"Lim","year":"2020","journal-title":"Oncologist"}],"container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-230032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:32:40Z","timestamp":1777383160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-230032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":15,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/bd-230032","relation":{},"ISSN":["0888-6008","1558-1551"],"issn-type":[{"value":"0888-6008","type":"print"},{"value":"1558-1551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}